Oncolytic viruses could be used to ‘warm up’ cold tumors and improve immunotherapy

Equipping cancer-infecting, or oncolytic, viruses with tumor-inhibiting genetic cargo stimulates the immune system and helps immunotherapy to shrink or completely clear aggressive tumors in mice, according to a new study in the Journal of Experimental Medicine led by University of Pittsburgh and UPMC researchers.

Is ‘Float Pool’ Nursing the Way Out of the Staffing Shortage?

Becky Kahn, Chief Client Officer at Works & Trusted Health It’s no secret that health systems across the U.S. continue to struggle with the nurse

March 27, 2024

Exclusive: Gene insertion startup launches with new integrase technology from University of Hawaii

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 9, 2024

BTK Inhibitor Likely to Get a Pass to Phase III in Uncontrolled Asthma

SAN DIEGO — Treatment with an investigational oral Bruton’s tyrosine kinase (BTK) inhibitor was associated with numerical decreases in loss of asthma control (LOAC) events

May 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.